Viemed Healthcare (VMD) Liabilities and Shareholders Equity (2018 - 2026)

Viemed Healthcare has reported Liabilities and Shareholders Equity for 9 years, with the latest figure at $197.4 million in Q1 2026.

• For the quarter ending Q1 2026, Liabilities and Shareholders Equity rose 10.83% year-over-year to $197.4 million; the trailing twelve-month figure through Mar 2026 stood at $783.5 million (up 13.77% YoY), and the FY2025 full-year result was $199.2 million, up 12.47% from the prior year.
• Liabilities and Shareholders Equity for Q1 2026 stood at $197.4 million, down from $199.2 million in the prior quarter.
• The five-year high for Liabilities and Shareholders Equity was $202.4 million in Q3 2025, with the low at $115.9 million in Q2 2022.
• Historically, Liabilities and Shareholders Equity has averaged $157.4 million across 5 years, with a median of $154.9 million in 2023.
• Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity fell 0.78% — and 2023, when it jumped 32.34%.
• Viemed Healthcare's Liabilities and Shareholders Equity stood at $117.0 million in 2022, then surged by 32.34% to $154.9 million in 2023, then rose by 14.32% to $177.1 million in 2024, then advanced by 12.47% to $199.2 million in 2025, then fell by 0.9% to $197.4 million in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $197.4 million (Q1 2026), $199.2 million (Q4 2025), and $202.4 million (Q3 2025), per Business Quant data.